New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export TVRD’s income statement to Excel — free account
Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
0.99
0.04
+4.21%
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
Shareholders’ equity is 65.7% of the balance sheet. What is a balance sheet?
Owns
$403.0KLong-term assets
$855.0KOther short-term assets
$22.3MCash & short-term investments
Funded by
$15.5MShareholders’ equity
$8.1MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 65.7%.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
22.28 | 15.77 | 24.98 | 30.81 |
+8 more quarters Free account |
Total current assets |
23.13 | 17.07 | 25.33 | 31.54 | |
Property, Plant, Equpment (Net) |
0.03 | 0.04 | 0.04 | 0.05 | |
Goodwill and Intangible Assets (Total) |
0.28 | 0.29 | 0.31 | 0.32 | |
Long-term assets (Other) |
0.02 | 0.02 | 0.02 | 0.02 | |
Total non-current assets |
0.40 | 0.45 | 0.49 | 0.54 | |
Total Assets |
23.53 | 17.52 | 25.82 | 32.07 | |
Accounts Payable |
2.08 | 4.64 | 4.62 | 3.22 | |
Accrued Expenses |
5.89 | 4.35 | 6.52 | 7.71 | |
Total current liabilities |
8.08 | 9.11 | 11.26 | 11.04 | |
Total non-current liabilities |
— | 0.02 | 0.05 | 0.09 | |
Total liabilities |
8.08 | 9.14 | 11.31 | 11.13 | |
Additional Paid In Capital |
145.28 | 132.08 | 131.75 | 131.38 | |
Common Stock (Net) |
0.01 | 0.01 | 0.01 | 0.01 | |
Retained Earnings |
(129.83) | (123.71) | (117.25) | (110.45) | |
Common Equity (Total) |
15.46 | 8.38 | 14.51 | 20.95 | |
Shareholders Equity (Total) |
15.46 | 8.38 | 14.51 | 20.95 | |
Shareholders Equity and Liabilities (Total) |
23.53 | 17.52 | 25.82 | 32.07 | |
Shares (Common) |
13.35 | 9.38 | 9.38 | 9,381.00 | |
Shareholders Equity (Tangible) |
15.18 | 8.09 | 14.20 | 20.62 | |
Net Debt |
(22.27) | (15.76) | (24.98) | (30.81) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 17, 2026